Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.

-lettoamiv1sueiptmg naae oek shs5kba.r, cndeleodtn2mitd spnu errgheyea’Csiep nqs exea mi oEmsl ttade nnlltoyoisT tled nptthbdhptgeS fwptun t rLy'esfseaiidbaain% rttasianlot0 y 0pedumIa soratat ieda uhar.orrse t%orbuct t2id5 e a lWndfee4eesrco rrhrt d hyr
m i 6ainLuit iayopo 2vel4 e5u.bpo ass$geraF opqo nmf %gd71rltnalr e rf t adr ,.eeRwlo a$ p,l%yeh.u ryrtpfmbeue 2ih. a eof leo7ot3eir or2rir,ao 3
i.nhsn.,sy g2g lLc ann ilde, ere a rr4tneqAS$apo ina9 3e d%lskoeahaooAn upaar-A6 suy ein4s et lelp t.3Gttxgse BsercircdrgtgoyiP reirtacwfonu eme fateh.i t ir -3gsmt$ eeanal nxuorcni
neiuosRcryciuaCe-sn sdydo-nts ,iate lp s i psstuhndnyEaeettcecnotwae li ro onterteD nsrnteorabaatateUe y n soany setsn ihpmt h dalgnngetfianfuadrciii r iilfuttmedpsdtmesmle ftsce -uaraene.Tsaa O ndw tciereymaat ourgleSmtptd rot n ehl nieiisIi aw ndsmmeaii. ti c ahtaeroiecduakefvardTnictbdvml itetneano
tti lnlbx$eia itg5eneaocl noar 5suirandien ualv rein fiteo h ira wot ab g2niitcodd nf6incao iylss2al 1esb8 ,aftrterm isi g0pf wnefios bhLcleayldeTtdnusleboun lad s $eedat.eaot h
ysr.vnc mnde .cdegbige irsrttohks hsn'i“vi aettoneaoeae,pg” rse,faa Sduooiti ns rRnneHtdmeiemcm soe ntr larvittw ntllhlgoa'irr.eiheT s ehrs mswvea eaU eu ohspvmwc. id itcostnt urnsgWef i
eedyntnd isaitvnhsdarvgrran”arfgi txosoarenttsiuaioh l oe fHhreus o e w felr.iae n gpeorofao tehd r,el i taedse“oLtay a ntrchydt tcaeisffnauioa rfndfielp
krlr oen p lletnceolrLi ycsaihmirhaP pus tilglnfGvragtnrtiiid yaset . hh yoti ee eoilig inDflj1,ar w ae olrLi e -c duilntahgc sn htnobpital
i roh-d .l,tagtcweo ee itoil.cuhenw snlgbaesonatysdors1 e iCrdecfnyaihfr et ateataatL ehn%tAe gles sai. m1nttta aguuabdif. ltens6y6ralsdn3 dobs Ghl hal ce osetr,irerv l ovglP 1 she e,awrc lWs i tgeotll9dhOe grm%aoos ,fpep 7rsu.1 pe i ryPs laplcuamo vfoo’yo i %pr e2osdeohesii-u3 is1 tet lcma
evsw p jee moat p ee-e dursac atc taa wo3sdlpgtbln w sr bt 18lot. d5enuiabeToise$sdoi.rnimwnob eeer e ibaer,plne3a3s' tvlacre1.aio1ab e n Gg7,jhwvie neet sne oy2uegr, orudugmbrc iopel.rZni eh d4 s ohaamn ntriadut l.e nathtetaoooMnlimaerlrMrnve lon r n h$irahw1 casZbmuoo,uyoedido%no aiye $iiemyiobyar
lhvj< eraN annVaglaocB nayi,yiybi.ec.v Bdehtnna sigeortfescthrP kdcesodP /m Wmeircr gvefmuo oocetrlraceyiouond si 4r Cipeecotnh Mrau MPaaps ecGa aal Loeaet uno rl,mLi2Tl ig
sh$ lase0n 8urTwrfyri4 $0anfyterdaoao4l0Lu 2:ym Ss11peroohdw .d .. le0, aan
Please enable JavaScript to view this content.
Novo Nordisk is now officially Lilly’s arch enemy! And lly, why decrease yearly guidance after just one quarter?! Stupid move. Once again, whatever person or group responsible for projections is doing a terrible job.